Ms. Jennifer Che, our President and Managing Director, spoke at the Hong Kong Intellectual Property Department’s IP Training Programme on patent commercialization and technology transfer. Since 2020, the IPD has partnered with the Vocational Training Council’s Institute of Professional Education and Knowledge to arrange various IP training programmes. Other speakers include Mr. Michael Lin – a strategic business consultant & President of IIPCC, Dr. David Ai from the London School of Economics and Political Science, and Dr. Vincent Zhong, an expert in IP licensing and technology transfer who worked at Netac Technology Co., Ltd.

Jennifer’s talk, titled ‘Building a Strategic Patent Portfolio for Commercialization,’ taught professionals how to strategically build patent portfolios with a business mindset. Aside from building IP, Jennifer also focused on topics such as IP licensing, ownership transfers, enforcement, and cross-border issues.

Attendees, including IP owners and executives from startups, SMEs, and large enterprises in the innovation sector, found her talk incredibly insightful and beneficial.

We are very thankful to the IPD and PEAK/VTC for this opportunity to help build a deeper understanding of IP and commercialization in Hong Kong.

我們過去活動

Recommended Insights

Burden Shift: CNIPA Requires Applicant to “Prove” that Post-Filing Data is not Fake Data

2025年4月1日
“Good Faith” is a challenging concept that brings with it the nuances of a particular jurisdiction’s ideas about honesty, moral values, and societal expectations. Most patent laws around the world include good faith requirements – especially in matters involving the legal and the medical profession – and China is no exception. So what’s the standard? […]
Tapentadol.svg

Polymorph Patents in China: What is the Standard for Inventiveness for New Crystal Forms?

2020年7月14日
This case is focused on polymorphs, namely what are the standards for novelty and inventiveness when it comes to new crystal forms of a known drug? A recent Supreme People’s Court decision in China is illustrative of the way Chinese courts are thinking about polymorph patents in China. Grünenthal is a German pharmaceutical company and […]

US vs CN: Foreign Filing License Requirements

2022年11月9日
In China, foreign filing requirements are generally very similar to the US — a foreign filing license is required if a foreign application is to be filed first for an invention made in the country. The Chinese equivalent to the US foreign filing license is called a confidentiality examination for foreign filing. According to Chinese […]

Narrow Claim Scope of a Chinese Utility Model Patent Fuels Design-Arounds by Failing to Curb Competing Products:

2020年10月28日
Learning from a 2019 China’s Top 50 Representative IP Case The number of patent applications in China is now the highest in the world, with more than half the applications filed as utility model applications (UMs). For example, there were more than 2 million UMs filed in 2018 alone (for the difference between a utility […]
Top crossarrow-right